Detalhe da pesquisa
1.
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
Proc Natl Acad Sci U S A
; 106(37): 15950-5, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717450
2.
The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
Mol Pharmacol
; 78(4): 648-57, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20660086
3.
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
J Pharmacol Exp Ther
; 328(3): 921-30, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088300
4.
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Bioorg Med Chem Lett
; 18(11): 3386-91, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18455394
5.
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput Screening.
ACS Chem Biol
; 12(2): 519-527, 2017 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032990
6.
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.
J Pharmacol Exp Ther
; 300(1): 305-13, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11752130
7.
N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity.
Proc Natl Acad Sci U S A
; 100(23): 13674-9, 2003 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-14595031